• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session

    9/22/23 2:22:36 PM ET
    $AMTI
    $AONC
    $ATEX
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Medical/Nursing Services
    Health Care
    Get the next $AMTI alert in real time by email

    Gainers

    MicroAlgo Inc. (NASDAQ:MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

    Synaptogenix, Inc. (NASDAQ:SNPX) surged 28.7% to $0.3610.

    Lifezone Metals Limited (NYSE:LZM) gained 27.4% to $15.29. Lifezone Metals recently reported H1 loss of $16.77 per share.

    SeqLL Inc. (NASDAQ:SQL) gained 26% to $18.04.

    Heart Test Laboratories, Inc. (NASDAQ:HSCS) climbed 25.2% to $0.4680.

    Cemtrex, Inc. (NASDAQ:CETX) rose 21.7% to $6.86.

    Cheche Group Inc. (NASDAQ:CCG) gained 21.1% to $17.99 amid continued volatility following the company's business combination with Prime Impact Acquisition I on Monday. The company today also said it has a successful, ongoing collaboration with Li Auto.

    Mondee Holdings, Inc. (NASDAQ:MOND) gained 20% to $4.1799. Mondee Holdings approved a $30 million share repurchase program to boost shareholder value.

    5E Advanced Materials, Inc. (NASDAQ:FEAM) gained 20% to $2.70 after the company announced it received authorization from the Environmental Protection Agency to conduct Step-Rate Testing under its existing permit.

    Shattuck Labs, Inc. (NASDAQ:STTK) jumped 19.6% to $1.83.

    Avalo Therapeutics, Inc. (NASDAQ:AVTX) shares rose 14.1% to $0.1169 after falling 8% on Thursday. The company recently agreed to divest AVTX-800 series.

    Globus Maritime Limited (NASDAQ:GLBS) gained 13.3% to $1.45.

    GSE Systems, Inc. (NASDAQ:GVP) shares rose 13.2% to $0.3497 after falling over 3% on Thursday.

    NextPlat Corp (NASDAQ:NXPL) gained 13.1% to $1.98.

    Solowin Holdings (NASDAQ:SWIN) rose 11.7% to $4.5250 after jumping 35% on Thursday.

    Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) shares climbed 11.7% to $4.09 as the company named Matthias Aydt as Global Chief Executive Officer, effective Sept. 29, 2023. The company also announced a management stock purchase plan.

    Anterix Inc. (NASDAQ:ATEX) gained 11.6% to $33.13. Anterix announced authorization of a new $250 million share repurchase program over three-year period.

    Secoo Holding Limited (NASDAQ:SECO) gained 9.9% to $0.3299.

    UP Fintech Holding Limited (NASDAQ:TIGR) surged 8.7% to $5.21.

    Losers

    Neptune Wellness Solutions Inc. (NASDAQ:NEPT) shares dipped 45.7% to $2.1708 after the company announced pricing of a $4.5 million public offering of 1.8 million shares at $2.50 per share.

    Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS) fell 33.3% to $1.4090 after jumping 26% on Thursday. Powerbridge Technologies expanded global trade digital platform services across Asia and Europe.

    Murphy Canyon Acquisition Corp. (NASDAQ:MURF) declined 31.2% to $11.69 amid volatility following the company's business combination with Conduit Pharmaceuticals.

    MSP Recovery, Inc. (NASDAQ:LIFW) fell 26.9% to $0.1738.

    FLJ Group Limited (NASDAQ:FLJ) fell 25.9% to $0.2260.

    VolitionRx Limited (NASDAQ:VNRX) declined 22.2% to $0.7928.

    Morphic Holding, Inc. (NASDAQ:MORF) fell 21.6% to $40.27.

    American Oncology Network Inc (NASDAQ:AONC) fell 19.2% to $16.58.

    TradeUP Acquisition Corp. (NASDAQ:UPTD) fell 17.5% to $12.60.

    Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) declined 17% to $3.28.

    Applied Molecular Transport Inc. (NASDAQ:AMTI) fell 16.7% to $0.17. Applied Molecular Transport agreed to merge with Cyclo Therapeutics Inc in an all-stock transaction.

    Flux Power Holdings, Inc. (NASDAQ:FLUX) fell 15.1% to $4.2004 following weaker-than-expected quarterly sales.

    Connexa Sports Technologies Inc. (NASDAQ:CNXA) fell 15% to $0.1330 after gaining over 17% on Thursday.

    Elutia Inc. (NASDAQ:ELUT) declined 14.4% to $1.31.

    Pharming Group N.V. (NASDAQ:PHAR) fell 14.1% to $12.90 after climbing around 15% on Thursday.

    Scholastic Corporation (NASDAQ:SCHL) shares fell 13.6% to $33.65 after the company reported downbeat results for its first quarter on Thursday.

    Molekule Group, Inc. (NASDAQ:MKUL) shares fell 10.8% to $0.3041 after dipping 19% on Thursday. Molekule Group recently announced in an 8K filing that the board authorized the management to commence preparation of voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

    MDB Capital Holdings, LLC (NASDAQ:MDBH) fell 9.8% to $11.27. MDB Capital raised $19,999,992 and started trading on the NASDAQ on Sept. 21, 2023.

    Empire State Realty OP, L.P. (NYSE:FISK) fell 8.6% to $7.41.

    Cepton, Inc. (NASDAQ:CPTN) declined 7.4% to $3.6201.

    PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) fell 7.2% to $6.22.

    Hertz Global Holdings, Inc. (NASDAQ:HTZ) fell 6.7% to $14.06.

    Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) declined 6.6% to $10.09.

    Now Read This: Nike, McDonald's And Other Consumer Stocks From Wall Street's Most Accurate Analysts

    Get the next $AMTI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AMTI
    $AONC
    $ATEX
    $AVTX

    CompanyDatePrice TargetRatingAnalyst
    Scholastic Corporation
    $SCHL
    3/9/2026Buy → Neutral
    B. Riley Securities
    Shattuck Labs Inc.
    $STTK
    3/6/2026$25.00Buy
    Needham
    Avalo Therapeutics Inc.
    $AVTX
    2/2/2026$50.00Buy
    Guggenheim
    Shattuck Labs Inc.
    $STTK
    1/28/2026$15.00Overweight
    Piper Sandler
    Avalo Therapeutics Inc.
    $AVTX
    12/18/2025$39.00Outperform
    Mizuho
    Shattuck Labs Inc.
    $STTK
    12/1/2025$6.00Neutral → Buy
    H.C. Wainwright
    UP Fintech Holding Ltd
    $TIGR
    10/23/2025$13.10Buy
    UBS
    UP Fintech Holding Ltd
    $TIGR
    9/29/2025$12.00Buy
    Jefferies
    More analyst ratings

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    NextPlat Announces 1-for-10 Reverse Stock Split to Be Effective Prior to Market Open on April 13, 2026

    HALLANDALE BEACH, Fla., April 2, 2026 /PRNewswire/ -- NextPlat Corp (NASDAQ:NXPL, NXPLW)) ("NextPlat" or the "Company"), a global consumer products and services company providing healthcare and technology solutions through e-commerce and retail channels worldwide, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Nevada to effect a one-for-ten (1:10) reverse stock split of its common stock. Following required notifications and receipt of approvals, the reverse stock split will now take effect at 12:01 am (Eastern Time) on April 13, 2026, and the Company's common stock will open for trading on The Nasdaq

    4/2/26 4:55:00 PM ET
    $NXPL
    Telecommunications Equipment
    Telecommunications

    Cheche Group Reports Second Half and Full Year 2025 Unaudited Financial Results

    BEIJING, April 2, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ:CCG) ("Cheche," "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the second half and full year ended December 31, 2025. Key Business HighlightsPartnerships with New Energy Vehicle (NEV) companies(1) reached 16 in the second half 2025 and led to 1.2 million policies with corresponding written premium of RMB3.7 billion (US$532.0 million), representing an increase of 61.8% and 63.9%, respectively, compared to the prior-year period. Embedded policies and corresponding written premium for the full year 2025 reached 2.0 million and RMB6.3 billion (US$902.1

    4/2/26 6:00:00 AM ET
    $CCG
    $NIO
    Specialty Insurers
    Finance
    Auto Manufacturing
    Industrials

    MicroAlgo Announces Substantial Increase of 143.5% in Net Profit for 2025

    SHENZHEN, China, April 1, 2026 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ:MLGO), (the "Company"), a leading developer and application provider of bespoke central processing algorithms, today announced its financial results for the year ended December 31, 2025. Financial Highlights 2025The Company's net profit for 2025 was RMB 127.56 million (USD 18.15 million), representing a substantial increase of 143.5% compared with the same period of the prior year, demonstrating the Company's strong profitability.Diluted earnings per share for 2025 were RMB 14.87 (USD 2.12), compared with RMB 3.99 in 2024, representing an increase of 272.7%.Total shareholders' equity more than doubled, reaching RMB 2,321.8

    4/1/26 9:00:00 AM ET
    $MLGO
    EDP Services
    Technology

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Scholastic Corp downgraded by B. Riley Securities

    B. Riley Securities downgraded Scholastic Corp from Buy to Neutral

    3/9/26 8:09:51 AM ET
    $SCHL
    Books
    Consumer Discretionary

    Needham resumed coverage on Shattuck Labs with a new price target

    Needham resumed coverage of Shattuck Labs with a rating of Buy and set a new price target of $25.00

    3/6/26 8:36:02 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Guggenheim initiated coverage on Avalo Therapeutics with a new price target

    Guggenheim initiated coverage of Avalo Therapeutics with a rating of Buy and set a new price target of $50.00

    2/2/26 6:51:00 AM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bep Special Situations Iv Llc bought $8,000,000 worth of shares (4,000,000 units at $2.00) (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/4/26 4:30:07 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    CFO Malm Joshua bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 263% to 5,175 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:48 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    Chief Executive Officer Weibel Paul Wesley Iii bought $7,500 worth of shares (3,750 units at $2.00), increasing direct ownership by 25% to 18,838 units (SEC Form 4)

    4 - 5E Advanced Materials, Inc. (0001888654) (Issuer)

    2/3/26 4:03:16 PM ET
    $FEAM
    Mining & Quarrying of Nonmetallic Minerals (No Fuels)
    Industrials

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Sullivan Christopher Ryan

    4 - Avalo Therapeutics, Inc. (0001534120) (Issuer)

    4/3/26 3:14:43 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Doyle Mittie

    4 - Avalo Therapeutics, Inc. (0001534120) (Issuer)

    4/3/26 3:13:22 PM ET
    $AVTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by West W Gilbert

    4 - HERTZ GLOBAL HOLDINGS, INC (0001657853) (Issuer)

    4/2/26 5:23:03 PM ET
    $HTZ
    Rental/Leasing Companies
    Consumer Discretionary

    $AMTI
    $AONC
    $ATEX
    $AVTX
    SEC Filings

    View All

    HeartSciences Inc. filed SEC Form 8-K: Leadership Update

    8-K - HeartSciences Inc. (0001468492) (Filer)

    4/3/26 5:15:10 PM ET
    $HSCS
    Industrial Specialties
    Health Care

    SEC Form 424B3 filed by Flux Power Holdings Inc.

    424B3 - Flux Power Holdings, Inc. (0001083743) (Filer)

    4/3/26 9:06:57 AM ET
    $FLUX
    Industrial Machinery/Components
    Miscellaneous

    Flux Power Holdings Inc. filed SEC Form 8-K: Other Events

    8-K - Flux Power Holdings, Inc. (0001083743) (Filer)

    4/3/26 9:03:28 AM ET
    $FLUX
    Industrial Machinery/Components
    Miscellaneous

    $AMTI
    $AONC
    $ATEX
    $AVTX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-8) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 02/24/2022. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    2/25/22 4:36:46 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for OCALIVA issued to INTERCEPT PHARMS INC

    Submission status for INTERCEPT PHARMS INC's drug OCALIVA (SUPPL-7) with active ingredient OBETICHOLIC ACID has changed to 'Approval' on 05/26/2021. Application Category: NDA, Application Number: 207999, Application Classification: Labeling

    5/27/21 5:23:24 AM ET
    $ICPT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Leadership Updates

    Live Leadership Updates

    View All

    Elutia Selects Pete Ligotti as CCO to Lead the Commercial Launch of NXT-41x and Transform Post-Mastectomy Care in the $1.5B U.S. Breast Surgery Market

    GAITHERSBURG, Md., March 02, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced the appointment of Pete Ligotti as Chief Commercial Officer. Mr. Ligotti will lead the commercialization for NXT-41x, Elutia's next-generation antibiotic-eluting biomatrix being developed to improve outcomes in plastic and reconstructive surgery. NXT-41x is Elutia's next-generation antibiotic-eluting biomatrix, built on the Company's validated drug-eluting platform. Elutia is applying that platform in plastic and reconstructive surgery, where breast reconstruction represents the largest and most underserved opportuni

    3/2/26 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Where Purpose Meets Performance: Elutia Earns 2026 Great Place to Work Certification™

    GAITHERSBURG, Md., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Elutia Inc. (NASDAQ:ELUT) ("Elutia" or the "Company"), a pioneer in drug-eluting biomatrix technologies, today announced that it has been Certified™ by Great Place to Work®, the leading organization that evaluates workplace culture through a standardized, anonymous employee survey methodology developed over 30 years of research. The certification recognizes organizations with high-trust workplace cultures, where sustained engagement and retention support consistent execution in regulated, innovation-driven industries. "Elutia isn't for everyone," said Dana Yoo, PhD, VP of Product Development. "The bar is high, and the work is hard. But

    2/18/26 8:00:00 AM ET
    $ELUT
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Volition Announces the Appointment of New Distributor for Nu.Q® Discover

    HENDERSON, Nev., Feb. 10, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, announces the appointment of Medical & Biological Laboratories Co. Ltd (MBL) as a non-exclusive distributor of its Nu.Q® Discover assays in Japan. Dr Jasmine Kway, Chief Executive Officer, Singapore Volition commented: "We are delighted to be working with MBL, a leading provider of clinical research tools in Japan, with a particular focus and track record in autoimmune diseases. "Through our Nu.Q® Discover pillar, we are now serving close to 100 clients worldwide, including many top pharma and diagnostic companies, accelerating disease research and drug developme

    2/10/26 8:07:00 AM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Financials

    Live finance-specific insights

    View All

    Cheche Group Reports Second Half and Full Year 2025 Unaudited Financial Results

    BEIJING, April 2, 2026 /PRNewswire/ -- Cheche Group Inc. (NASDAQ:CCG) ("Cheche," "the Company" or "we"), China's leading auto insurance technology platform, today announced its unaudited financial results for the second half and full year ended December 31, 2025. Key Business HighlightsPartnerships with New Energy Vehicle (NEV) companies(1) reached 16 in the second half 2025 and led to 1.2 million policies with corresponding written premium of RMB3.7 billion (US$532.0 million), representing an increase of 61.8% and 63.9%, respectively, compared to the prior-year period. Embedded policies and corresponding written premium for the full year 2025 reached 2.0 million and RMB6.3 billion (US$902.1

    4/2/26 6:00:00 AM ET
    $CCG
    $NIO
    Specialty Insurers
    Finance
    Auto Manufacturing
    Industrials

    MicroAlgo Announces Substantial Increase of 143.5% in Net Profit for 2025

    SHENZHEN, China, April 1, 2026 /PRNewswire/ -- MicroAlgo Inc. (NASDAQ:MLGO), (the "Company"), a leading developer and application provider of bespoke central processing algorithms, today announced its financial results for the year ended December 31, 2025. Financial Highlights 2025The Company's net profit for 2025 was RMB 127.56 million (USD 18.15 million), representing a substantial increase of 143.5% compared with the same period of the prior year, demonstrating the Company's strong profitability.Diluted earnings per share for 2025 were RMB 14.87 (USD 2.12), compared with RMB 3.99 in 2024, representing an increase of 272.7%.Total shareholders' equity more than doubled, reaching RMB 2,321.8

    4/1/26 9:00:00 AM ET
    $MLGO
    EDP Services
    Technology

    VolitionRx Limited Announces Full Fiscal Year 2025 Financial Results and Business Update

    Conference call to discuss financial and operational results scheduled forWednesday, April 1 at 8:30 a.m. U.S. Eastern TimeHENDERSON, Nev., March 31, 2026 /PRNewswire/ -- VolitionRx Limited (NYSE:VNRX) ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the full fiscal year 2025.  Volition management will host a conference call tomorrow, April 1 at 8:30 a.m. U.S. Eastern Time/2:30 p.m. Central European Time to discuss these results. Conference call details can be found below. Cameron Reynolds, President and Group Chief Executive Officer, said:"We set out over fifteen years ago to help save lives and improve outcomes for millions of

    3/31/26 4:05:00 PM ET
    $VNRX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    $AMTI
    $AONC
    $ATEX
    $AVTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by MSP Recovery Inc.

    SC 13D/A - MSP Recovery, Inc. (0001802450) (Subject)

    12/17/24 4:05:04 PM ET
    $LIFW
    EDP Services
    Technology

    SEC Form SC 13G filed by PMV Pharmaceuticals Inc.

    SC 13G - PMV Pharmaceuticals, Inc. (0001699382) (Subject)

    12/12/24 12:29:41 PM ET
    $PMVP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Anterix Inc.

    SC 13D/A - Anterix Inc. (0001304492) (Subject)

    12/9/24 8:45:15 PM ET
    $ATEX
    Telecommunications Equipment
    Telecommunications